Medipal Holdings Corporation - Unsponsored ADR logo

Medipal Holdings Corporation - Unsponsored ADR (MAHLY)

Market Closed
11 Aug, 20:00
OTC PINK OTC PINK
$
17. 37
0
0%
$
3.56B Market Cap
13.58 P/E Ratio
0.89% Div Yield
20 Volume
0 Eps
$ 17.37
Previous Close
Add Transaction
Day Range
17.37 18.95
Year Range
15.37 20.35
Want to track MAHLY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

MAHLY closed today higher at $17.37, an increase of 0% from yesterday's close, completing a monthly increase of 6.6953% or $1.09. Over the past 12 months, MAHLY stock lost -2.9609%.
MAHLY pays dividends to its shareholders, with the most recent payment made on Jun 17, 2025. The next announced payment will be in In 3 months on Dec 02, 2026 for a total of $0.00177.
The last earnings report, released on May 11, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.1616%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

MAHLY Chart

People also search for

Tsingtao Brewery Co. Ltd. Sponsored ADR
$ 29
-4.8556%
Addtech AB Unsponsored ADR
$ 18.67
-0.0696%
China Resources Beer (Holdings) Company Limited ADR
$ 5.7
-2.0619%
China Mengniu Dairy Company Limited
$ 23.63
-1.4184%
Shiseido Company, Limited Sponsored ADR
$ 22.78
-0.1753%

Medipal Holdings Corporation - Unsponsored ADR (MAHLY) FAQ

What is the stock price today?

The current price is $17.37.

On which exchange is it traded?

Medipal Holdings Corporation - Unsponsored ADR is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is MAHLY.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.89%.

What is its market cap?

As of today, the market cap is 3.56B.

Has Medipal Holdings Corporation - Unsponsored ADR ever had a stock split?

No, there has never been a stock split.

Medipal Holdings Corporation - Unsponsored ADR Profile

Consumer Staples Distribution & Retail Industry
Consumer Staples Sector
Shuichi Watanabe CEO
OTC PINK Exchange
58502T107 CUSIP
JP Country
13,024 Employees
29 Sep 2026 Last Dividend
- Last Split
- IPO Date

Overview

Medipal Holdings Corporation, rooted in its rich history since 1898, stands as a pivotal entity in the pharmaceutical wholesale sector in Japan. Initially known as Mediceo Paltac Holdings Co., Ltd., the company underwent a name change to Medipal Holdings Corporation in October 2009, marking a significant milestone in its evolution. With its headquarters in Tokyo, Japan, Medipal has expanded its reach, catering to a diverse range of healthcare needs. The company's core lies in the prescription pharmaceutical wholesale business, complemented by a broad spectrum of healthcare products and services. These range from diagnostics and testing to treatment and administration solutions, encompassing an extensive variety of medical equipment, materials, and clinical diagnostic reagents right from the pre-symptomatic stage. Medipal's commitment extends beyond mere distribution, delving into PMS services for manufacturers, orphan drug investments, and a multitude of other health-related ventures. This comprehensive approach positions Medipal as a central figure in the healthcare industry, dedicated to fostering well-being across numerous facets of healthcare and related fields.

Products and Services

  • Healthcare Products Distribution:

    Medipal excels in the distribution of a wide array of healthcare products. This includes medical equipment and materials vital for diagnostics, testing, treatment, and administration. Additionally, the company distributes clinical diagnostic reagents crucial for the pre-symptomatic stage of diseases, showcasing its comprehensive coverage of healthcare needs.

  • PMS Services and Orphan Drug Investments:

    The company takes on PMS (Post-Marketing Surveillance) services under contract for manufacturers, ensuring the safety and efficacy of pharmaceuticals post-launch. Moreover, Medipal actively invests in orphan drugs, highlighting its commitment to addressing rare diseases and supporting innovative healthcare solutions.

  • Wholesale of Cosmetics and Daily Necessities:

    Beyond pharmaceuticals, Medipal's business extends to the wholesale of cosmetics, daily necessities, and OTC (Over-The-Counter) pharmaceuticals, catering to a broader spectrum of consumer health and well-being.

  • Animal Health Products:

    The company also focuses on animal health, offering products for companion animals. This not only includes medications but also encompasses food processing raw materials and livestock feed additives, showing Medipal’s dedication to a comprehensive approach to health that spans both human and animal needs.

  • Additional Services:

    Medipal's services further extend into contract-based epidemiological and clinical studies, creation of specialized medical databases, and the operation of class A health dispensing pharmacies. Moreover, it engages in a variety of sectors including life and non-life insurance agency business, cleaning management, distribution center operations, delivery services, and employee dispatch. Their engagement in medical consulting and administrative outsourcing further showcases their versatile approach to healthcare industry needs. Additionally, the company actively participates in the trade of medical clerks and the distribution of specialty pharmaceuticals, alongside providing contract logistics services and information provision services to a diverse clientele that includes hospitals, clinics, drugstores, and various consumer outlets, alongside businesses in the livestock and fishery sectors, and processed food manufacturers.

Contact Information

Address: 2-7-15, Yaesu
Phone: 81 3 3517 5800